Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Tubulis: The company raised EUR 344 million of Series C venture funding in a deal led by Venrock on October 30, 2025. Andera Partners, Frazier Healthcare Partners, Blackstone,...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions OpenEvidence: The company raised $200 million of Series C venture funding in a deal led by GV on October 20, 2025, putting the company’s pre-money valuation at $5.8 billion....
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Kailera Therapeutics: The company is in the process of raising $600 million of an undisclosed targeted amount of Series B venture funding in a deal led by Bain Capital on October 14,...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $96 million of Series C venture funding from undisclosed investors on October 7, 2025. The company is a drug development business designed to...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Star Therapeutics: The company raised $125 million of Series D venture funding in a deal led by Sanofi Ventures and Viking Global Investors on September 30, 2025. NYBC Ventures,...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Judi Health: The company closed on $252 million of a targeted $400 million of Series F venture funding in a deal led by General Catalyst and Wellington Management on September 23,...
